L-Cysteine | Licensing, EU CTD Dossiers, Formulation Listed Suppliers | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

L-Cysteine
Listed Dossiers

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

L-Cysteine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

9 API Suppliers, 1 USDMF, 1 CEP/COS, 4 JDMF, 4 Listed Suppliers, $ API Reference Price

9 API Suppliers
1 USDMF
1 CEP/COS
4 JDMF
4 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

4 FDF Dossiers, 1 Canada, 1 South Africa, 2 Listed Dossiers

4 FDF Dossiers
1 Canada
1 South Africa
2 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Gangwal Healthcare, 1 Pfanstiehl, 4 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 BASF, 1 Gangwal Chemicals, 4 Kerry, 5 Microlex e.U, 2 Pluviaendo, 1 Prachin Chemical, 1 Roquette, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Vasa Pharmachem

1 Gangwal Healthcare
1 Pfanstiehl
4 Actylis
1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
2 BASF
1 Gangwal Chemicals
4 Kerry
5 Microlex e.U
2 Pluviaendo
1 Prachin Chemical
1 Roquette
1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

8 Lubricants & Glidants, 6 Fillers, Diluents & Binders, 5 Parenteral, 4 Co-Processed Excipients, 4 Coating Systems & Additives, 3 Thickeners and Stabilizers, 3 Controlled & Modified Release, 3 Direct Compression, 2 Granulation, 2 Taste Masking, 1 Emulsifying Agents, 1 Topical, 1 Film Formers & Plasticizers

8 Lubricants & Glidants
6 Fillers, Diluents & Binders
5 Parenteral
4 Co-Processed Excipients
4 Coating Systems & Additives
3 Thickeners and Stabilizers
3 Controlled & Modified Release
3 Direct Compression
2 Granulation
2 Taste Masking
1 Emulsifying Agents
1 Topical
1 Film Formers & Plasticizers

DIGITAL CONTENT

8 NEWS #PharmaBuzz

8 NEWS #PharmaBuzz

MARKET PLACE

11 APIs, 1 EXCIPIENTS

11 APIs
1 EXCIPIENTS

REF. STANDARDS & IMPURITIES

3 EDQM, 4 USP, 18 Others

3 EDQM
4 USP
18 Others

ANALYTICAL

1 Analytical Methods

1 Analytical Methods

$ API Ref.Price (USD/KG) : 20 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

2 All

01 2Intas Pharmaceuticals

filter Active Ingredients Reset all filters

2 All

01 2L-Cysteine

filter Dosage Reset all filters

2 All

01 2Effervescent Tablet

filter Dosage Strength Reset all filters

2 All

01 1200MG

02 1600MG

filter Country Reset all filters

2 All

01 2India

List of Suppliers

Product Main Page

01

Intas Pharmaceuticals

2024 ACI Convention

Not Confirmed

Intas Pharmaceuticals

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : India

Brand Name :

Dosage Form : Effervescent Tablet

Dosage Strength : 200MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

01

Intas Pharmaceuticals

2024 ACI Convention

Not Confirmed

Intas Pharmaceuticals

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Packaging :

Regulatory Info :

Dosage : Effervescent Tablet

Dosage Strength : 200MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Intas Pharmaceuticals

2024 ACI Convention

Not Confirmed

Intas Pharmaceuticals

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : India

Brand Name :

Dosage Form : Effervescent Tablet

Dosage Strength : 600MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Intas Pharmaceuticals

2024 ACI Convention

Not Confirmed

Intas Pharmaceuticals

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Packaging :

Regulatory Info :

Dosage : Effervescent Tablet

Dosage Strength : 600MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?